Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.12
-0.02 (-0.28%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $48.29 million as of July 31, 2026. Its market cap has decreased by -72.75% in one year.
Market Cap
48.29M
Enterprise Value
58.90M
1-Year Change
-72.75%
Ranking
Category
Stock Price
$7.12
ChartMarket Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $48.29M, a decrease of -98.08%. That is a compound annual growth rate of -52.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 48.29M | -35.27% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 52.31M |
| Filana Therapeutics | 48.79M |
| TScan Therapeutics | 48.56M |
| aTyr Pharma | 47.62M |
| Immutep | 47.59M |
| BeyondSpring | 47.29M |
| Seres Therapeutics | 46.77M |
| INmune Bio | 46.52M |